nutrients Review Phytochemicals as Therapeutic Interventions in Peripheral Artery Disease Ahmed Ismaeel 1, K. Leigh Greathouse 1,2 , Nathan Newton 3, Dimitrios Miserlis 4 , Evlampia Papoutsi 1, Robert S. Smith 5, Jack L. Eidson 5, David L. Dawson 5, Craig W. Milner 5, Robert J. Widmer 6 , William T. Bohannon 5 and Panagiotis Koutakis 1,* 1 Department of Biology, Baylor University, Waco, TX 76798, USA;
[email protected] (A.I.);
[email protected] (K.L.G.);
[email protected] (E.P.) 2 Department of Human Sciences and Design, Baylor University, Waco, TX 76798, USA 3 Department of Chemistry and Biochemistry, Baylor University, Waco, TX 76798, USA;
[email protected] 4 Department of Surgery, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA;
[email protected] 5 Department of Surgery, Baylor Scott & White Medical Center, Temple, TX 76508, USA;
[email protected] (R.S.S.);
[email protected] (J.L.E.);
[email protected] (D.L.D.);
[email protected] (C.W.M.);
[email protected] (W.T.B.) 6 Heart & Vascular Department, Baylor Scott & White Medical Center, Temple, TX 76508, USA;
[email protected] * Correspondence:
[email protected] Citation: Ismaeel, A.; Greathouse, Abstract: Peripheral artery disease (PAD) affects over 200 million people worldwide, resulting in K.L.; Newton, N.; Miserlis, D.; significant morbidity and mortality, yet treatment options remain limited. Among the manifestations Papoutsi, E.; Smith, R.S.; Eidson, J.L.; of PAD is a severe functional disability and decline, which is thought to be the result of different Dawson, D.L.; Milner, C.W.; Widmer, pathophysiological mechanisms including oxidative stress, skeletal muscle pathology, and reduced R.J.; et al.